These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2300238)

  • 1. T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors.
    Hartung HP; Hughes RA; Taylor WA; Heininger K; Reiners K; Toyka KV
    Neurology; 1990 Feb; 40(2):215-8. PubMed ID: 2300238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
    Taylor WA; Hughes RA
    J Neuroimmunol; 1989 Sep; 24(1-2):33-9. PubMed ID: 2808686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
    J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome.
    Bansil S; Mithen FA; Cook SD; Sheffet A; Rohowsky-Kochan C
    Neurology; 1991 Aug; 41(8):1302-5. PubMed ID: 1866024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.
    Hohnoki K; Inoue A; Koh CS
    J Neuroimmunol; 1998 Jul; 87(1-2):27-32. PubMed ID: 9670842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of soluble form of selectin family in the sera of patients with neuroimmunological disorders].
    Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):197-202. PubMed ID: 9711113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.
    Chalon MP; Sindic CJ; Laterre EC
    Acta Neurol Scand; 1993 Feb; 87(2):77-82. PubMed ID: 8442399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases.
    Van den Berg LH; Mollee I; Wokke JH; Logtenberg T
    J Neuroimmunol; 1995 Apr; 58(1):37-42. PubMed ID: 7730448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of soluble form of L-selectin in blood of patients with neuroimmunological disorders].
    Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
    Arerugi; 1996 Jul; 45(7):672-7. PubMed ID: 8831172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
    J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated demyelination.
    Hartung HP
    Ann Neurol; 1993 Jun; 33(6):563-7. PubMed ID: 8498835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ben-Smith A; Gaston JS; Barber PC; Winer JB
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):362-8. PubMed ID: 8890774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases].
    Shimada K; Koh CS; Yanagisawa N
    Arerugi; 1993 Aug; 42(8):934-40. PubMed ID: 8250733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
    Patzold T; Sindern E; Ossege-Pohle L; Malin JP
    J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.